• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[新生婴儿中萘啶酸(Negram)的胎盘转运及药代动力学研究]

[Placental passage of nalidixic acid (Negram) and pharmacokinetic studies in the newborn infant].

作者信息

Peiker G, Traeger A

出版信息

Pharmazie. 1983 Sep;38(9):613-5.

PMID:6647535
Abstract

Nalidixic acid and hydroxynalidixic acid penetrate the placenta during labour. During the first 24 h of life the serum concentrations of nalidixic acid and nalidixic acid plus hydroxynalidixic acid decline slowly and show individual differences. The changed kinetic parameter in the newborn, especially the delayed elimination of nalidixic acid as well as nalidixic acid plus hydroxynalidixic acid lead to the consequence of recommendation of a very strong therapeutic indication in the peripartal period.

摘要

萘啶酸和羟基萘啶酸在分娩时可透过胎盘。在出生后的头24小时内,萘啶酸以及萘啶酸与羟基萘啶酸之和的血清浓度缓慢下降,并存在个体差异。新生儿体内药代动力学参数的改变,尤其是萘啶酸以及萘啶酸与羟基萘啶酸之和的消除延迟,导致围产期需有非常明确的治疗指征。

相似文献

1
[Placental passage of nalidixic acid (Negram) and pharmacokinetic studies in the newborn infant].[新生婴儿中萘啶酸(Negram)的胎盘转运及药代动力学研究]
Pharmazie. 1983 Sep;38(9):613-5.
2
Pharmacokinetic model for nalidixic acid in man. I. Kinetic pathways for hydroxynalidixic acid.
J Pharm Sci. 1966 Jan;55(1):59-62. doi: 10.1002/jps.2600550113.
3
Hydroxylation and oxidation of nalidixic acid in the turtle Pseudemys scripta elegans.秀丽锦龟中萘啶酸的羟基化和氧化作用
Vet Q. 1988 Jan;10(1):67-9. doi: 10.1080/01652176.1988.9694149.
4
Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tablets.人用未包衣片剂中萘啶酸的生物利用度——第一部分:与片剂溶出速率的相关性
Int J Clin Pharmacol Ther Toxicol. 1984 Apr;22(4):175-83.
5
[Studies on the pharmacokinetics of nalidixic acid in children of different ages].[不同年龄段儿童萘啶酸的药代动力学研究]
Z Kinderheilkd. 1970;109(2):124-34.
6
The biosynthesis of hydroxynalidixic acid.
Acta Microbiol Acad Sci Hung. 1975;22(4):433-45.
7
[New investigation of the pharmacokinetics of nalidixic acid. I. Serum and urinary levels with normal renal function].[萘啶酸药代动力学的新研究。I. 肾功能正常时的血清和尿液水平]
Arzneimittelforschung. 1973 Sep;23(9):1311-3.
8
[The pharmacokinetics of nalidixic acid administered parenterally. Towards rational use in severe infections (author's transl)].[萘啶酸经胃肠外给药的药代动力学。关于其在严重感染中的合理应用(作者译)]
Nouv Presse Med. 1979 May 26;8(23):1911-4.
9
Pharmacokinetic model for nalidixic acid in man. II. Parameters for absorption, metabolism, and elimination.
J Pharm Sci. 1966 Jan;55(1):72-8. doi: 10.1002/jps.2600550116.
10
Disposition of valproic acid in maternal, fetal, and newborn sheep. I: placental transfer, plasma protein binding, and clearance.丙戊酸在母羊、胎儿和新生羊体内的处置。I:胎盘转运、血浆蛋白结合及清除率。
Drug Metab Dispos. 2000 Jul;28(7):845-56.

引用本文的文献

1
The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state.血浆蛋白结合对药物在稳态时胎儿/母体分布的意义。
Clin Pharmacokinet. 1988 Mar;14(3):156-70. doi: 10.2165/00003088-198814030-00004.
2
Species differences in pharmacokinetics and drug teratogenesis.药代动力学和药物致畸作用中的物种差异。
Environ Health Perspect. 1986 Dec;70:113-29. doi: 10.1289/ehp.8670113.